Showing results (1-10 of 521) with videos related to

Sort By:
Pageof 53
Current Opinion in Cardiology|August 30, 2019
Modulation of cholesterol efflux capacity in patients with myocardial infarctionJohanne Silvain, Mathieu Kerneis, Maryse Guerin, et al.
The American Journal of Cardiology|March 3, 2015
Updates and current recommendations for the management of patients with non-ST-elevation acute coronary syndromes: what it means for clinical practiceGuillaume Cayla, Johanne Silvain, Jean-Philippe Collet, et al.
Medecine Sciences : M/S|April 2, 2014
[Coronary stents: 30 years of medical progress]Johanne Silvain, Guillaume Cayla, Jean-Philippe Collet, et al.
Presse Medicale (Paris, France : 1983)|April 23, 2011
[Myocardial infarction: Role of new antiplatelet agents]Johanne Silvain, Anne Bellemain, Patrick Ecollan, et al.
Revue Medicale Suisse|February 25, 2014
[Cardiology. Platelet function testing for clinicians]Cyril Pellaton, Eric Eeckhout, Johanne Silvain, et al.
International Journal of Cardiology|June 20, 2012
An evidence-based review of current anti-platelet options for STEMI patientsGuillaume Cayla, Johanne Silvain, Stephen A O'Connor, et al.
Expert Review of Cardiovascular Therapy|November 9, 2011
Antiplatelet options for secondary prevention in acute coronary syndromesJohanne Silvain, Guillaume Cayla, Stephen A O'Connor, et al.
Progress in Cardiovascular Diseases|January 18, 2018
Anticoagulation in Acute Coronary Syndrome-State of the ArtMichel Zeitouni, Mathieu Kerneis, Tarek Nafee, et al.
International Journal of Cardiology|November 25, 2010
Prevalence and clinical impact of Upper Gastrointestinal Symptoms in subjects treated with low dose aspirin: the UGLA surveyGuillaume Cayla, Jean-Philippe Collet, Johanne Silvain, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 18, 2016
Dual antiplatelet therapy: optimal timing, management, and durationPierre Sabouret, Sophie K Rushton-Smith, Mathieu Kerneis, et al.
Pageof 53